Moolec Science Merges with Bioceres Group in $500M Deal

Moolec Science has announced a major all-stock merger with Bioceres Group and related entities, consolidating interests in Bioceres, Nutrecon, and Gentle Technologies to form an enlarged corporate structure with Moolec as the parent company. The transaction, approved unanimously by the involved boards and supported by a majority of Moolec shareholders, will see up to 87 million new shares and 5 million warrants issued to stakeholders of the contributing entities. This strategic move aims to enhance Moolec's capabilities in molecular farming, seed and microbe modification, and regenerative agriculture, while managing a combined portfolio of over 800 patents and 550 product registrations across more than 50 countries. Leaders from both companies emphasized the merger’s potential to drive agricultural innovation, sustainability, and operational synergies, positioning Moolec as a key player in the agricultural sector. The agreement is expected to close in the second quarter of 2025, pending regulatory and shareholder approvals, and will include a leadership transition with Gaston Paladini stepping down as CEO and Chairman. The merger is anticipated to improve market position, diversify product offerings, and increase cost efficiencies and revenue growth for the combined entity.